Literature DB >> 21933876

Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort.

Fuat Kurbanov1, Mohamed Abdel-Hamid, Rachel Latanich, Jacquie Astemborski, Mostafa Mohamed, Nabiel Mh Mikhail, Mai El-Daly, Sherif El-Kafrawy, David L Thomas, Chloe L Thio.   

Abstract

Single-nucleotide polymorphisms (SNPs) around IL28B are associated with spontaneous hepatitis C virus (HCV) clearance of genotypes 1 and 3 in white and African-American populations. This study investigated whether the IL28B SNP (rs12979860) is associated with spontaneous clearance of HCV, principally genotype 4, in 162 Egyptians (80 with clearance). The protective C allele was more common in those with spontaneous clearance (76.3% vs 57.9%; P = .0006). Individuals with clearance were 3.4 (95% confidence interval, 1.8-6.5) times more likely to have C/C genotype. Thus, IL28B plays a role in spontaneous clearance of HCV genotype 4 in North Africa.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933876      PMCID: PMC3182308          DOI: 10.1093/infdis/jir536

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.

Authors:  Norma I Rallón; Susanna Naggie; José M Benito; José Medrano; Clara Restrepo; David Goldstein; Kevin V Shianna; Eugenia Vispo; Alex Thompson; John McHutchison; Vincent Soriano
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

2.  The natural history of hepatitis C virus infection: host, viral, and environmental factors.

Authors:  D L Thomas; J Astemborski; R M Rai; F A Anania; M Schaeffer; N Galai; K Nolt; K E Nelson; S A Strathdee; L Johnson; O Laeyendecker; J Boitnott; L E Wilson; D Vlahov
Journal:  JAMA       Date:  2000-07-26       Impact factor: 56.272

3.  Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients coinfected with HIV and hepatitis C virus.

Authors:  Juan A Pineda; Antonio Caruz; Antonio Rivero; Karin Neukam; Irene Salas; Angela Camacho; José C Palomares; José A Mira; Antonio Martínez; Carmen Roldán; Julián de la Torre; Juan Macías
Journal:  Clin Infect Dis       Date:  2010-10-01       Impact factor: 9.079

Review 4.  Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6.

Authors:  Mindie H Nguyen; Emmet B Keeffe
Journal:  Clin Gastroenterol Hepatol       Date:  2005-10       Impact factor: 11.382

5.  A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Authors:  Hans L Tillmann; Alex J Thompson; Keyur Patel; Manfred Wiese; Hannelore Tenckhoff; Hans D Nischalke; Yuliya Lokhnygina; Ulrike Kullig; Uwe Göbel; Emanuela Capka; Johannes Wiegand; Ingolf Schiefke; Wolfgang Güthoff; Kurt Grüngreiff; Ingrid König; Ulrich Spengler; Jeanette McCarthy; Kevin V Shianna; David B Goldstein; John G McHutchison; Jörg Timm; Jacob Nattermann
Journal:  Gastroenterology       Date:  2010-07-14       Impact factor: 22.682

6.  Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study.

Authors:  Andri Rauch; Zoltán Kutalik; Patrick Descombes; Tao Cai; Julia Di Iulio; Tobias Mueller; Murielle Bochud; Manuel Battegay; Enos Bernasconi; Jan Borovicka; Sara Colombo; Andreas Cerny; Jean-François Dufour; Hansjakob Furrer; Huldrych F Günthard; Markus Heim; Bernard Hirschel; Raffaele Malinverni; Darius Moradpour; Beat Müllhaupt; Andrea Witteck; Jacques S Beckmann; Thomas Berg; Sven Bergmann; Francesco Negro; Amalio Telenti; Pierre-Yves Bochud
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

7.  Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.

Authors:  Mohamed Abdel-Hamid; Mai El-Daly; Vilma Molnegren; Sherif El-Kafrawy; Sohair Abdel-Latif; Gamal Esmat; G Thomas Strickland; Christopher Loffredo; Jan Albert; Anders Widell
Journal:  J Gen Virol       Date:  2007-05       Impact factor: 3.891

8.  Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication.

Authors:  Abeer Elkady; Yasuhito Tanaka; Fuat Kurbanov; Fuminaka Sugauchi; Masaya Sugiyama; Anis Khan; Douaa Sayed; Ghada Moustafa; Abdel-Rahman Abdel-Hameed; Masashi Mizokami
Journal:  J Med Virol       Date:  2009-06       Impact factor: 2.327

9.  Genetic epidemiology of hepatitis C virus throughout egypt.

Authors:  S C Ray; R R Arthur; A Carella; J Bukh; D L Thomas
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

10.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962

View more
  18 in total

1.  An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Alnoor Ramji; Marc Bilodeau; Stephen Wong; Jordan J Feld
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

Review 2.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

3.  Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.

Authors:  Zainab A Zakaria; Susanne Knapp; Mohamed Hashem; Hassan Zaghla; Mark Thursz; Imam Waked; Sayed Abdelwahab
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

4.  An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.

Authors:  Robert P Myers; Hemant Shah; Kelly W Burak; Curtis Cooper; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2015-01-13

5.  Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.

Authors:  Susanne Knapp; Zainab Zakaria; Mohamed Hashem; Hassan Zaghla; Salim I Khakoo; Imam Waked; Mark Thursz; Sayed F Abdelwahab
Journal:  Hepatol Int       Date:  2015-03-12       Impact factor: 6.047

6.  IFNL3 genotype is associated with differential induction of IFNL3 in primary human hepatocytes.

Authors:  Fuat Kurbanov; Yonghak Kim; Rachel Latanich; Pooja Chaudhari; Ramy El-Diwany; Matt Knabel; Abraham J Kandathil; Andrew Cameron; Andrea Cox; Yoon-Young Jang; David L Thomas; Ashwin Balagopal
Journal:  Antivir Ther       Date:  2015-06-25

7.  Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

Authors:  Moutaz Derbala; Nasser Rizk; Fatima Shebl; Saad Alkaabi; Nazeeh Eldweik; Anil John; Manik Sharma; Rafie Yaqoob; Muneera Almohanadi; Mohammed Butt; Khaled Alejji
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 8.  Burden of pediatric hepatitis C.

Authors:  Mortada Hassan El-Shabrawi; Naglaa Mohamed Kamal
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

9.  Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis.

Authors:  Hamid Heidarian Miri; Pooria Fazeli; Mohammad Ali-Hassanzadeh; Peyman Bemani; Dieter Kabelitz; Kurosh Kalantar
Journal:  Arch Virol       Date:  2021-07-03       Impact factor: 2.574

10.  Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.

Authors:  Mohamed Hashem; Ravi Jhaveri; Doa'a A Saleh; Sahar A Sharaf; Fatma El-Mougy; Lobna Abdelsalam; Michelle D Shardell; Hesham El-Ghazaly; Samer S El-Kamary
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.